AU2002316577A1 - Cell-screening assay and composition - Google Patents

Cell-screening assay and composition

Info

Publication number
AU2002316577A1
AU2002316577A1 AU2002316577A AU2002316577A AU2002316577A1 AU 2002316577 A1 AU2002316577 A1 AU 2002316577A1 AU 2002316577 A AU2002316577 A AU 2002316577A AU 2002316577 A AU2002316577 A AU 2002316577A AU 2002316577 A1 AU2002316577 A1 AU 2002316577A1
Authority
AU
Australia
Prior art keywords
cell
composition
screening assay
assay
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002316577A
Inventor
Po-Ying Chan-Hui
Sharat Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monogram Biosciences Inc
Original Assignee
Aclara Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aclara Biosciences Inc filed Critical Aclara Biosciences Inc
Publication of AU2002316577A1 publication Critical patent/AU2002316577A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
AU2002316577A 2001-07-09 2002-07-05 Cell-screening assay and composition Abandoned AU2002316577A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30429601P 2001-07-09 2001-07-09
US60/304,296 2001-07-09
US32529201P 2001-09-27 2001-09-27
US60/325,292 2001-09-27
PCT/US2002/021339 WO2003006947A2 (en) 2001-07-09 2002-07-05 Cell-screening assay and composition

Publications (1)

Publication Number Publication Date
AU2002316577A1 true AU2002316577A1 (en) 2003-01-29

Family

ID=26973933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002316577A Abandoned AU2002316577A1 (en) 2001-07-09 2002-07-05 Cell-screening assay and composition

Country Status (2)

Country Link
AU (1) AU2002316577A1 (en)
WO (1) WO2003006947A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
WO2004087887A2 (en) 2003-04-01 2004-10-14 Monogram Biosciences, Inc. Intracellular complexes as biomarkers
WO2009086197A1 (en) 2007-12-20 2009-07-09 Monogram Biosciences, Inc. Her-2 diagnostic methods
WO2010065568A2 (en) 2008-12-01 2010-06-10 Laboratory Corporation Of America Holdings METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
CN102460152B (en) 2009-01-15 2014-11-26 美国控股实验室公司 Methods of determining patient response by measurement of her-3
US10724099B2 (en) 2012-03-16 2020-07-28 The Broad Institute, Inc. Multiplex methods to assay mixed cell populations simultaneously
EP2904390B1 (en) 2012-10-02 2016-11-16 Roche Diagnostics GmbH Methods of specifically releasing a sub-group of objects
US10451614B2 (en) 2016-03-15 2019-10-22 Laboratory Corporation Of America Holdings Methods of assessing protein interactions between cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725535A (en) * 1983-02-22 1988-02-16 Sonenshein Abraham L Promoter probe vectors
US5658736A (en) * 1996-01-16 1997-08-19 Genetics Institute, Inc. Oligonucleotide population preparation

Also Published As

Publication number Publication date
WO2003006947A3 (en) 2003-05-08
WO2003006947A2 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002334307A1 (en) Novel lna compositions and uses thereof
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002350105A1 (en) Novel quinazolines and uses thereof
AU2002367404A1 (en) Redox-switchable materials
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002353861A1 (en) Assay
AU2002359392A1 (en) Rapid prion-detection assay
AU2002241114A1 (en) Composition
AU2002324450A1 (en) Novel pyridopyrimidines and uses thereof
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2002316577A1 (en) Cell-screening assay and composition
AUPR446801A0 (en) Novel compositions and uses therefor
AU2002251543A1 (en) Novel atisane compound and use thereof
AU5240901A (en) Assay
AU2002359869A1 (en) Pak5-related compositions and methods
AU2001276499A1 (en) Assay
AU3389501A (en) Assay
AU2002349088A1 (en) Compositions and methods for AA4RP assay
AU2002312558A1 (en) Novel pyridopyrimidones and uses thereof
AU2002322287A1 (en) Novel idolinones and uses thereof
AUPR369101A0 (en) Compositions and uses therefor - iv

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase